Day One
Track 1: Antibody-Based Molecular Engineering
Track 2: Emerging Techniques For Bioanalysis & Characterisation and Quality Control Systems
Day Two
Track 1: Computational Tools, AI/ML & Structural Approaches & inEngineering
Track 2: Multi Specific Antibodies, Cell Engagers & Other New Modalities
Vladimir Gligorijevic - Genentech
Samuel Pine - Sanofi
Maria Tsoumpeli - Cancer Research Horizons, AstraZeneca Antibody Alliance Laboratory
Nadim Ahktar - AstraZeneca
Isabel Aznarez - Stoke Therapeutics
David Brayden - University College Dublin
Generated by meetings and positions 5.0 by Kai Garlipp WWW: Kai Garlipp, Frank S. Zollmann. 7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.